Monitoring of Myeloid Malignancies in the Era of Next Generation Sequencing
Wed., Jan.16, 2019
12:00 PM ET/9:00 AM PT
Register now for this live educational webinar where Dr Racke will discuss incorporation of new molecular markers into the diagnostic algorithms for myeloid neoplasms, illustrate the principle of molecular monitoring in prognostic and therapeutic assessment of myeloid neoplasms, explain the benefits and pitfalls in the use of next-generation sequencing (NGS) for the workup of low-grade MDS.
Frederick K. Racke, MD, PhD
Medical Director, Hematology/Oncology and Coagulation
Quest Diagnostics Nichols Institute
San Juan Capistrano, CA
ONE contact hour toward ASCLS P.A.C.E.® credit will be available to participating laboratory professionals who attend the webinar and complete the post evaluation.